Federal Register / Vol. 87, No. 121 / Friday, June 24, 2022 / Notices 37879 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Hematology and Vascular Biology. 

Date: July 15, 2022. 

Time: 2:00 p.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Larry Pinkus, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4132, 

MSC 7802, Bethesda, MD 20892, (301) 435– 

1214, pinkusl@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: Vascular and Hematology. 

Date: July 19, 2022. 

Time: 2:00 p.m. to 8:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Larry Pinkus, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4132, 

MSC 7802, Bethesda, MD 20892, (301) 435– 

1214, pinkusl@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: HIV/AIDS Behavioral. 

Date: July 21–22, 2022. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Ananya Paria, DHSC, 

MPH, MS, Scientific Review Officer, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 1007H, 

Bethesda, MD 20892, (301) 827–6513, 

pariaa@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: June 17, 2022. 

Victoria E. Townsend, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–13477 Filed 6–23–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Medical Imaging Investigations. 

Date: July 26, 2022. 

Time: 10:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Yuanna Cheng, MD, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4138, 

MSC 7814, Bethesda, MD 20892, (301) 435– 

1195, Chengy5@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: June 17, 2022. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–13478 Filed 6–23–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

U.S. Customs and Border Protection 

[CBP Dec. 22–13] 

Western Hemisphere Travel Initiative: 

Designation of an Approved Native 

American Tribal Card Issued by the 

Kickapoo Traditional Tribe of Texas as 

an Acceptable Document To Denote 

Identity and Citizenship for Entry in the 

United States at Land and Sea Ports of 

Entry 

AGENCY: U.S. Customs and Border 

Protection, DHS. 

ACTION: Notice. 

SUMMARY: This notice announces that 

the Commissioner of U.S. Customs and 

Border Protection is designating an 

approved Native American tribal card 

issued by the Kickapoo Traditional 

Tribe of Texas to U.S. citizen tribal 

members as an acceptable travel 

document for purposes of the Western 

Hemisphere Travel Initiative. The 

approved card may be used to denote 

identity and citizenship of Kickapoo 

Traditional Tribe of Texas members 

entering the United States from 

contiguous territory or adjacent islands 

at land and sea ports of entry. 

DATES: This designation will become 

effective on June 24, 2022. 

FOR FURTHER INFORMATION CONTACT: 

Adele Fasano, Executive Director, 

Planning, Program Analysis, and 

Evaluation, Office of Field Operations, 

U.S. Customs and Border Protection, via 

email at Adele.Fasano@cbp.dhs.gov. 

SUPPLEMENTARY INFORMATION: 

Background 

The Western Hemisphere Travel 

Initiative 

Section 7209 of the Intelligence 

Reform and Terrorism Prevention Act of 

2004 (IRTPA), Public Law 108–458, as 

amended, required the Secretary of 

Homeland Security, in consultation 

with the Secretary of State, to develop 

and implement a plan to require U.S. 

citizens and individuals for whom 

documentation requirements have 

previously been waived under section 

212(d)(4)(B) of the Immigration and 

Nationality Act (8 U.S.C. 1182(d)(4)(B)) 

to present a passport or other document 

or combination of documents as the 

Secretary deems sufficient to denote 

identity and citizenship for all travel 

into the United States. See 8 U.S.C. 1185 

note. On April 3, 2008, the Department 

of Homeland Security (DHS) and the 

Department of State promulgated a joint 

final rule, effective on June 1, 2009, that 


jspears on DSK121TN23PROD with NOTICES1